Table 1 Demographic and clinical characteristics of type 2 diabetic patients with and without peripheral neuropathy
From: Tumor necrosis factor alpha in peripheral neuropathy in type 2 diabetes mellitus
Demographic data | Patients group | Control group | Statistical analysis | |||
|---|---|---|---|---|---|---|
Group (I) N = 40 | Group (II) N = 40 | Group (III) N = 40 | F/χ2 | P value | Post hoc | |
Gender (No. %) | ||||||
Male | 17 (42.5%) | 16 (40%) | 20 (50%) | 0.879 | 0.644 | |
Female | 23 (57.5%) | 24 (60%) | 20 (50%) | |||
Age (years) | 0.061 | |||||
Mean ± SD | 55.9 ± 8.2 | 59.3 ± 7.7 | 56.7 ± 7.1 | 2.16 | 0.12 | 0.652 |
Range | 45.0–65.0 | 49.0–68.0 | 35.0–45 | 0.123 | ||
BMI (kg/m2) | 0.551 | |||||
Mean ± SD | 31.9 ± 5.3 | 32.7 ± 6.3 | 29.1 ± 3.4 | 5.40 | 0.006 | 0.0062 |
Range | 25.8–36.8 | 25.8–39.8 | 25.7–39.8 | 0.0023 | ||
Systolic BP(mmHg) | 0.531 | |||||
Mean ± SD | 141.3 ± 8.5 | 142.6 ± 9.7 | 132.5 ± 8.2 | 15.5 | < 0.001 | < 0.0012 |
Range | 130.0–155.0 | 130.0–155.0 | 120–144 | < 0.0013 | ||
Diastolic BP (mmHg) | 0.481 | |||||
Mean ± SD | 86.3 ± 8.1 | 87.5 ± 7.0 | 82.7 ± 5.7 | 5.09 | 0.008 | 0.022 |
Range | 80.0–95.0 | 80.0–95.0 | 75.0–90.0 | 0.0013 | ||
Duration of neuropathy | ||||||
Mean ± SD | 3.8 ± 0.5 | 7.6 ± 1.1 | t test | < 0.001 | ||
Range | 3.0–4.5 | 6.0–9.0 | 15.18 | |||